Overview
Ronald Kubica is an Oncologist and a Hematologist in Albuquerque, New Mexico. Dr. Kubica is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Lynch Syndrome. Dr. Kubica is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER COMMERCIAL
Locations
4901 Lang Ave Ne, New Mexico Cancer Center, Albuquerque, NM 87109
Nexus Health
David Snyder is a Hematologist Oncology specialist and an Oncologist in Santa Fe, New Mexico. Dr. Snyder is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Common Variable Immune Deficiency, Lung Cancer, and Colorectal Cancer.
Presbyterian Healthcare Services
Ethan Binder is a Hematologist Oncology specialist and a Hematologist in Rio Rancho, New Mexico. Dr. Binder is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Choriocarcinoma, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Breast Cancer.
New Mexico Oncology Hematology Consultants Ltd
Katherine Sanchez is an Oncologist and a Hematologist Oncology provider in Albuquerque, New Mexico. Dr. Sanchez is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma. Dr. Sanchez is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Kubica isDistinguished. Learn about Breast Cancer.
- Colorectal CancerDr. Kubica isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Kubica isDistinguished. Learn about Familial Colorectal Cancer.
- Lynch SyndromeDr. Kubica isDistinguished. Learn about Lynch Syndrome.
- Paget Disease of the BreastDr. Kubica isDistinguished. Learn about Paget Disease of the Breast.
- Polycythemia VeraDr. Kubica isDistinguished. Learn about Polycythemia Vera.
- Advanced
- Adult Immune ThrombocytopeniaDr. Kubica isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Kubica isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Kubica isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Kubica isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Kubica isAdvanced. Learn about Angiosarcoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acquired AgranulocytosisDr. Kubica isExperienced. Learn about Acquired Agranulocytosis.
- Acute Lymphoblastic Leukemia (ALL)Dr. Kubica isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kubica isExperienced. Learn about Acute Myeloid Leukemia (AML).